BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35674873)

  • 1. Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice.
    Shoaf ML; Desjardins A
    Neurotherapeutics; 2022 Oct; 19(6):1818-1831. PubMed ID: 35674873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
    Suryawanshi YR; Schulze AJ
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Virotherapy for the Treatment of Malignant Glioma.
    Foreman PM; Friedman GK; Cassady KA; Markert JM
    Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of immune cells in oncolytic herpes simplex virotherapy for glioma.
    Otani Y; Yoo JY; Shimizu T; Kurozumi K; Date I; Kaur B
    Brain Tumor Pathol; 2022 Apr; 39(2):57-64. PubMed ID: 35384530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success.
    Hervás-Corpión I; Alonso MM
    Int Rev Cell Mol Biol; 2023; 379():169-188. PubMed ID: 37541723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.
    Asija S; Chatterjee A; Goda JS; Yadav S; Chekuri G; Purwar R
    Front Immunol; 2023; 14():1118246. PubMed ID: 37006286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.
    Estevez-Ordonez D; Chagoya G; Salehani A; Atchley TJ; Laskay NMB; Parr MS; Elsayed GA; Mahavadi AK; Rahm SP; Friedman GK; Markert JM
    Neurosurg Clin N Am; 2021 Apr; 32(2):265-281. PubMed ID: 33781507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promises of oncolytic viral therapy for adult and children with brain glioma.
    Patiño-García A; Alonso MM; Gállego Pérez-Larraya J
    Curr Opin Oncol; 2023 Nov; 35(6):529-535. PubMed ID: 37820087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword.
    Blitz SE; Kappel AD; Gessler FA; Klinger NV; Arnaout O; Lu Y; Peruzzi PP; Smith TR; Chiocca EA; Friedman GK; Bernstock JD
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncolytic viruses for therapy of malignant glioma].
    Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
    Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.
    Wollmann G; Ozduman K; van den Pol AN
    Cancer J; 2012; 18(1):69-81. PubMed ID: 22290260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies.
    Shah S
    Med Sci (Basel); 2023 Dec; 12(1):. PubMed ID: 38249077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy.
    Shin DH; Nguyen T; Ozpolat B; Lang F; Alonso M; Gomez-Manzano C; Fueyo J
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic vaccinia virus and cancer immunotherapy.
    Xu L; Sun H; Lemoine NR; Xuan Y; Wang P
    Front Immunol; 2023; 14():1324744. PubMed ID: 38283361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application.
    Hua L; Wakimoto H
    Expert Opin Biol Ther; 2019 Aug; 19(8):845-854. PubMed ID: 31046478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gospel of malignant Glioma: Oncolytic virus therapy.
    Li J; Meng Q; Zhou X; Zhao H; Wang K; Niu H; Wang Y
    Gene; 2022 Apr; 818():146217. PubMed ID: 35093451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes.
    Malogolovkin A; Gasanov N; Egorov A; Weener M; Ivanov R; Karabelsky A
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma.
    Cuoco JA; Rogers CM; Mittal S
    Neurosurg Focus; 2021 Feb; 50(2):E8. PubMed ID: 33524945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.